Novi Yanti Sari: When MPNs Affect the Heart
Novi Yanti Sari, Lecturer at Universitas Pelita Harapan, shared a post on LinkedIn about a recent article by Orly Leiva et al, published in Journal of the American College of Cardiology, adding:
”Beyond thrombosis: what cardiovascular complications should we look for in patients with MPN?
This review highlights that the CV burden extends beyond arterial & venous thrombosis:
- HF may be more prevalent in MPNs than in general population, with worse HF-specific outcomes reported in myelofibrosis
- Traditional CV risk factors are less common in these patients, suggesting a distinct HF phenotype PH is common and may be pre-capillary, post-capillary or combined, requiring careful haemodynamic evaluation. Echo First is the recommended screening tool, with RHC for definitive diagnosis
- PH screening should be considered in patients with myelofibrosis, long-standing MPN, signs of disease progression and cardiomegaly Emerging data suggest that both HF and PH may be associated with adverse cardiovascular outcomes and hematologic progression in MPN, highlighting potential shared pathophysiology such as chronic inflammation and JAK/STAT pathway activation.”
Title: Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review
Authors: Orly Leiva, Olivia Liu, Anthony Kanelidis, Stanley Swat, Leo Gozdecki, Mark Belkin, Jonathan Grinstein, Sara Kalantari, Gene Kim, Jeanne DeCara, Ben Chung, Anand Patel, Olatoyosi Odenike, Eric H. Yang, Michelle Bloom, Jose Alvarez-Cardona, Joan How, Gabriela Hobbs.

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks